China Pharma Holdings (CPHI) Payables (2010 - 2026)

China Pharma Holdings' Payables history runs 17 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• Quarterly Payables fell 30.29% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 30.29% YoY) and the FY2025 annual result came in at $2.3 million, down 30.1% from the prior year.
• Payables was $2.3 million for Q1 2026 at China Pharma Holdings, down from $2.3 million in the prior quarter.
• Across five years, Payables topped out at $6.2 million in Q4 2022 and bottomed at $338414.0 in Q1 2022.
• A 5-year average of $2.5 million and a median of $2.3 million in 2025 frame the typical range for Payables.
• Annual changes were most pronounced in 2022 — Payables sank 88.54% — and 2023, when it soared 1082.54%.
• China Pharma Holdings' Payables stood at $6.2 million in 2022, then slumped by 66.07% to $2.1 million in 2023, then jumped by 58.46% to $3.3 million in 2024, then sank by 30.1% to $2.3 million in 2025, then declined by 0.99% to $2.3 million in 2026.
• Business Quant data shows CPHI's Payables at $2.3 million in Q1 2026, $2.3 million in Q4 2025, and $3.7 million in Q3 2025.